Meanwhile back over at Cellmid ASX: CDY .028 some punters on Hot Copper are looking forward to royalty payments from Pacific Edge based on extra sales personnel being hired.
Printable View
Meanwhile back over at Cellmid ASX: CDY .028 some punters on Hot Copper are looking forward to royalty payments from Pacific Edge based on extra sales personnel being hired.
Skid, do you really believe that after all this time, planning, research, development, selection and forward thinking, establishing goals and doing their utmost to meet them, building relationships, signing up providers, bringing more products to commercialization - that they havent thought about this matter and have just been standing around waving a placard with Over Here written on it. Becoming aware! Some of you people really sell things short.
If you believe that then you should send that email pronto
Noah Fence
Thats just the way I see it and will remain that way until PROVEN otherwise.
It’s always good when you are invested into a positive demographic trend.
http://www.medscape.com/viewarticle/803670
If the number of US Urologists is expected to decline by 29% by 2025 when the number of bladder cancer patients is increasing at 3% p.a, then it may very well create a tailwind for Cxbladder diagnostic tests over significantly more labour intensive invasive procedures.
It is only through people "bailing" Croesus that has helped cause the SP to drop. If those premature disbelieving "bailers" were instead believing sincere "holders" - the buyers would have no stock to buy. Or, in other words, if Supply did not outstrip Demand then the price would be more stable and upright. Don't want to sound harsh, but if for whatever reason one wants to "bail" and the timing is wrong - there is going to be a price to pay. I am genuinely sorry for your mate who lost $140k.
I've noted this before...if you draw a line under the SP from about Sept 2012 through to Nov 2013 through to where it is now - (IMVHO) it is pretty much on a sensible growth trajectory in line with developments and achievements. The aberration (madness?) between Oct 2013 and February 2014 is simply a demonstration of those ever lurking traders trying to make a fast buck by speculating. Only trouble is, when the market catches up (as it always does) ... its the ones left trying to catch the falling knives that get cut up the worst. As the old saying goes ... if you want to live by the sword - you have to be prepared to die by the sword. Ruthless but true. Again (IMVHO) PEB is not a traders stock.
I am still happy holding - but will certainly have some questions ready for the AGM.
Hi there Moosie....lovely day for ducks down here today.
Your answer has very ably demonstrated/confirmed the point I was trying to make....which is, long term investors don't use a company's stock as a short term financial whore to make money for themselves. Traders do that. Traders do not have the same interest in the long term financial wellbeing of a Company that investors do (in fact they don't care about the wellbeing of a company - period!). They are simply going in and out of a company's stock at the whim of other traders who have a contrarian view at any one time. I am sure you have quoted Ben Graham and Buffet etc - both of whom are investors - not traders. I have read the "intelligent investor" but have yet to read the "intelligent trader".
In my view, traders are nothing more than market manipulators - just as in currency trading. The fact that 97% of all currency trading is done by traders/speculators is absolutely frightening! I wonder what the ratio is for stock market trading?
Agree with that blackcap, traders offer opportunities for investors when buying or exiting over longer time frames.
Dentie's relevant point is more in respect of Pacific Edge having many key fundamental elements in its favour, a leading technology, a superior product to any in the market, urologist numbers are falling away and Pacific Edge have a product which is a clinically better than what they presently do and a labour saving methodology.
Unlike some entirely spec stocks, the company has a product with good efficacy to offer into an established clinical market.
A two year overlay chart of XRO and PEB reveals, I think it is fair to say with a smile, that traders can't yet tell the difference between pissing in a plastic sample bottle and accounting software.
I put this down to a lack of analyst coverage, but that may well change over the coming months as they come on board, and the market should thus then have a better valuation reference for stock picking and value investing, let’s see.
Yep - I absolutely agree with you BC...one provides liquidity for the other.
Was just stating my opinion - was not trying to say either are wrong. I guess, in some sort of way, I was trying to say that not all stocks are appropriate for trading all the time. For me, those young companies that are trying to get stability in their market as they try and grow by gaining a decent amount of market share (& thus a fair market valuation) shouldn't have their share price ravaged by traders who are simply trying to make as much money as quickly as possible. This type of activity could easily make or break the future of a company - which would be unfortunate.
Sorry MAC - must have been typing at the same time.
Dentie said - the point I was trying to make....which is, long term investors don't use a company's stock as a short term financial whore to make money for themselves.
Seems Mr Swann et all and no doubt several of the long term investors on this site thought that ridiculously high prices in excess of $1.50 was a good time to cash up some of their holdings (maybe in some cases to cover most of the cash they have actually given to PEB) ..... whores?